HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heo, T.-H. Articles by Kang, C.-Y. Search for Related Content PubMed PubMed Citation Articles by Heo, T.-H. Articles by Kang, C.-Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Incomplete Humoral Immunity against Hepatitis C Virus Is Linked with Distinct Recognition of Putative Multiple Receptors by E2 Envelope Glycoprotein¹

Tae-Hwe Heo^*, Jae-Hoon Chang^*, Jae-Woo Lee^*, Steven K. H. Foung, Jean Dubuisson and Chang-Yuil Kang^2,*

^* Laboratory of Immunology and Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea; Department of Pathology, Stanford University, Stanford, CA 94304; and Centre National de la Recherche Scientifique, Unité Propre de Recherche 2511, Institut de Biologie de Lille, Institut Pasteur de Lille, Lille, France

Little is known about the role of the humoral immune response to hepatitis C virus (HCV). This study provides molecular evidence for the mechanism by which neutralizing Abs from the sera of chronic HCV patients have lower inhibitory activities against the binding of HCV E2 envelope protein to human hepatoma cell lines than to a lymphoma cell line. E2 binds to several putative receptors, specifically human CD81; human scavenger receptor, class B, type 1; and heparan sulfate. We have shown that E2 binds to target cells via these receptors in a noncompetitive manner. Thus, incomplete inhibition of one of the receptors leads to only a partial E2 blockade and, possibly, evasion of the host immune response. We demonstrated that the difference in and reduction of inhibition was closely related to impaired blockade of E2 binding to scavenger receptor, class B, type 1, and heparan sulfate. We have also shown that soluble E2 protein binds to multiple soluble receptors via separate binding domains on E2, providing further evidence for the distinct recognition of multiple cellular receptors by E2. This report suggests a novel finding that biased humoral immune responses to HCV E2 might provide an alternative mechanism for viral escape without the involvement of mutation. Additionally, our data give crucial consideration to the development of HCV vaccines that stimulate protective humoral immune responses.

This article has been cited by other articles:

				K Murao, H Imachi, X Yu, W M Cao, T Nishiuchi, K Chen, J Li, R A M Ahmed, N C W Wong, and T Ishida Interferon {alpha} decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes Gut, May 1, 2008; 57(5): 664 - 671. [Abstract] [Full Text] [PDF]

				R. J. P. Brown, A. W. Tarr, C. P. McClure, V. S. Juttla, N. Tagiuri, W. L. Irving, and J. K. Ball Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes J. Gen. Virol., February 1, 2007; 88(2): 458 - 469. [Abstract] [Full Text] [PDF]

				M. Dreux, T. Pietschmann, C. Granier, C. Voisset, S. Ricard-Blum, P.-E. Mangeot, Z. Keck, S. Foung, N. Vu-Dac, J. Dubuisson, et al. High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI J. Biol. Chem., July 7, 2006; 281(27): 18285 - 18295. [Abstract] [Full Text] [PDF]

				H. Barth, R. Cerino, M. Arcuri, M. Hoffmann, P. Schurmann, M. I. Adah, B. Gissler, X. Zhao, V. Ghisetti, B. Lavezzo, et al. Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of Primary Tupaia Hepatocytes J. Virol., May 1, 2005; 79(9): 5774 - 5785. [Abstract] [Full Text] [PDF]